Learn more about ACRO’s advocacy efforts in the United States and Europe
Artificial Intelligence & Machine Learning
ACRO’s AI/ML Committee brings together member company subject matter experts engaged in the development and use of AI/ML tools in the design, conduct, oversight, and analysis of clinical trials.
Diversity & Inclusion in Clinical Trials
ACRO’s Diversity and Inclusion in Clinical Trials Committee was formed in 2020 as a part of ACRO’s ongoing efforts to work towards advancing diversity, equity, and inclusion in the clinical research ecosystem.
Risk-Based Quality Management
Risk-based monitoring is an adaptive approach that directs monitoring focus and activities to the evolving areas of greatest need which have the most potential to impact patient safety and data quality.
ACRO MEMBERS
US Advocacy
ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
European Advocacy
ACRO engages with regulators and policymakers in the EU and UK to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
Subscribe for Updates
The Association of Clinical Research Organizations (ACRO) represents the leading clinical research and technology companies around the world. In our newsletter, we bring you updates on our work and the impact that we are having in advancing the global clinical research industry.
The Latest
ACRO Partners with TransCelerate BioPharma to Release Four New Data Governance Resources
Today, ACRO announced four new data governance resource, co-developed with TransCelerate BioPharma. Created to assist key…
RBQM: A Case for Centralized Monitoring
This week, ACRO’s Good Clinical Podcast returns for a special episode! Lauren Garson (Senior Director, Clinical Strategy,…
ACRO Announces Recipients of Diversity & Inclusion Site Resource Grants
ACRO is pleased to announce the seven clinical research sites that will receive grant funding…
ACRO Announces 2025 Officers and New Members
WASHINGTON, DC – Washington DC – ACRO today announced that its Board of Directors elected…
ACRO Summary Report Highlights Key Findings from RBQM Landscape Survey
In 2024, ACRO’s RBQM Working Group conducted the fifth consecutive year of its annual risk-based…
ACRO Releases Latest RBQM Publication Providing Real-World Use Case of Centralized Monitoring Implementation
In ACRO’s latest paper published in DIA’s Therapeutic Innovation and Regulatory Science, “Risk-Based Quality Management: A Case…
ACRO Releases Publication Showcasing Benefits of Centralized Monitoring Implementation Through Real-World Use Case
WASHINGTON, DC – Today, ACRO’s RBQM Working Group has announced the publication of its latest…